Results
Balaxi Pharmaceuticals Q1 FY27 Revenue Up 14% YoY
Balaxi Pharmaceuticals reported Q1 FY27 consolidated revenue of ₹80.68 crore, a 14% YoY increase, with PAT surging 347% to ₹1.29 crore.
The company commenced commercial production at its first pharmac
